of the Treasury shall organize under the laws of a State a corporation to be known as the Rare Disease Therapeutics Corporation (hereinafter in this Act referred to as the Corporation ). (2) Qualified portfolio manager As soon as practicable after organization, the Corporation shall hire a qualified portfolio manager whose mandate will be to acquire and manage a portfolio of biomedical research assets on behalf of the Corporation. (b) Purpose The purpose of the Corporation shall be to purchase rights to, fund the development of, and, once developed, sell ownership interests in rare disease therapeutics. (c) Privatization of the Corporation (1) In general As soon as practicable after the establishment of the Corporation, but in no case later than 2 years after the date of enactment of this Act, the Secretary shall issue equity stock in the Corporation to private investors. (2) Termination of Government ownership Upon the issuance of the equity stock described under paragraph (1), the Government shall no longer hold any ownership interest in the Corporation. (3) Prohibition on dividends The Corporation may not pay dividends on the equity stock of the Corporation while there are any outstanding guaranteed bonds of the Corporation issued pursuant to subsection (e)(1)(A). (d) Sale of ownership interests (1) In general The Corporation— (A) may sell a rare disease therapy owned by the Corporation at any time